Confirmations by other patients, a more detailed analysis of intronic regions, or hopefully the programmed development of a suitable cell model, will confirm our hypothesis that IBD impairment combined with ETFDH heterozygosity could be sufficient to generate MADD phenotype. This evidence concerns the gene ETFDH and multiple acyl-CoA dehydrogenase deficiency.